A Prospective, With One Site, Open-label Not Controled Trial, for the Observation of Treatment With CIDOFOVIR 1%, 3 Nights Per Week, During 4 Weeks, of Anal Intraepithelial Neoplasia, High Level, in HIV+ Patients

NCT01946009 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

HIV

Interventions

DRUG: Cidofovir 1% cream's basis, 2gr, three times per week, during 4 weeks.

Sponsor

Fundacion SEIMC-GESIDA